SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.155-3.1%Dec 2 12:50 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Yang who wrote (994)12/29/1998 10:35:00 AM
From: Fred Levine  Read Replies (1) of 1605
 
Sorry, I used the word inevitable as my opinion and it should have been labeled as such. I do know that the EECP article is being revised for publication and will be published. Once the data are published, as opposed to presented at conferences, the logic is that here is a treatment that is cheaper and safer than invasive alternatives and therefore the inevitability of reimbursement. In addition, since many insurance companies do reimburse, IMO, it becomes more difficult to be turned down by the others.

fred
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News